MutS homologue hMSH4: Interaction with eIF3f and a role in NHEJ-mediated DSB repair

Molecular Cancer

Volumn 12, Issue 1, 2013, Pages

  Chu, Yen Lin ^a   Wu, Xiling ^a   Xu, Yang ^a   Her, Chengtao ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

eIF3f; hMSH4; Ionizing radiation (IR); Non homologous end joining (NHEJ)

Indexed keywords

ELF3F PROTEIN; HISTONE H2AX; PROTEIN; PROTEIN KINASE B; PROTEIN MSH4; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL SURVIVAL; CONTROLLED STUDY; DNA END JOINING REPAIR; DNA REPAIR; DOUBLE STRANDED DNA BREAK; DOWN REGULATION; ENZYME ACTIVATION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; IONIZING RADIATION; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RADIATION INJURY; TREATMENT RESPONSE;

CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL LINE; CELL SURVIVAL; DNA END-JOINING REPAIR; ENZYME ACTIVATION; EUKARYOTIC INITIATION FACTOR-3; HUMANS; PROTEIN BINDING; PROTEIN STABILITY; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84878357168     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-12-51     Document Type: Article

References (56)

1. Moynahan ME, Jasin M. Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis. Nat Rev Mol Cell Biol 2010, 11:196-207. 10.1038/nrm2851, 3261768, 20177395.
2. Lieber MR. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem 2010, 79:181-211. 10.1146/annurev.biochem.052308.093131, 3079308, 20192759.
3. Deans AJ, West SC. DNA interstrand crosslink repair and cancer. Nat Rev Cancer 2011, 11:467-480. 10.1038/nrc3088, 3560328, 21701511.
4. Helleday T, Lo J, van Gent DC, Engelward BP. DNA double-strand break repair: from mechanistic understanding to cancer treatment. DNA Repair (Amst) 2007, 6:923-935.
5. Surtees JA, Argueso JL, Alani E. Mismatch repair proteins: key regulators of genetic recombination. Cytogenet Genome Res 2004, 107:146-159. 10.1159/000080593, 15467360.
6. Chen W, Jinks-Robertson S. The role of the mismatch repair machinery in regulating mitotic and meiotic recombination between diverged sequences in yeast. Genetics 1999, 151:1299-1313. 1460550, 10101158.
7. Datta A, Hendrix M, Lipsitch M, Jinks-Robertson S. Dual roles for DNA sequence identity and the mismatch repair system in the regulation of mitotic crossing-over in yeast. Proc Natl Acad Sci USA 1997, 94:9757-9762. 10.1073/pnas.94.18.9757, 23263, 9275197.
8. Wang Q, Ponomareva ON, Lasarev M, Turker MS. High frequency induction of mitotic recombination by ionizing radiation in Mlh1 null mouse cells. Mutat Res 2006, 594:189-198. 10.1016/j.mrfmmm.2005.09.005, 16343558.
9. Siehler SY, Schrauder M, Gerischer U, Cantor S, Marra G, Wiesmuller L. Human MutL-complexes monitor homologous recombination independently of mismatch repair. DNA Repair (Amst) 2009, 8:242-252.
10. Xu K, Wu X, Tompkins JD, Her C. Assessment of anti-recombination and double-strand break-induced gene conversion in human cells by a chromosomal reporter. J Biol Chem 2012, 287:29543-29553. 10.1074/jbc.M112.352302, 22773873.
11. Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, Qin J. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 2000, 14:927-939. 316544, 10783165.
12. Her C, Zhao N, Wu X, Tompkins JD. MutS homologues hMSH4 and hMSH5: diverse functional implications in humans. Front Biosci 2007, 12:905-911. 10.2741/2112, 17127347.
13. Neyton S, Lespinasse F, Moens PB, Paul R, Gaudray P, Paquis-Flucklinger V, Santucci-Darmanin S. Association between MSH4 (MutS homologue 4) and the DNA strand-exchange RAD51 and DMC1 proteins during mammalian meiosis. Mol Hum Reprod 2004, 10:917-924. 10.1093/molehr/gah123, 15489243.
14. Novak JE, Ross-Macdonald PB, Roeder GS. The budding yeast Msh4 protein functions in chromosome synapsis and the regulation of crossover distribution. Genetics 2001, 158:1013-1025. 1461720, 11454751.
15. Santucci-Darmanin S, Walpita D, Lespinasse F, Desnuelle C, Ashley T, Paquis-Flucklinger V. MSH4 acts in conjunction with MLH1 during mammalian meiosis. FASEB J 2000, 14:1539-1547. 10.1096/fj.14.11.1539, 10928988.
16. Snowden T, Acharya S, Butz C, Berardini M, Fishel R. hMSH4-hMSH5 recognizes Holliday Junctions and forms a meiosis-specific sliding clamp that embraces homologous chromosomes. Mol Cell 2004, 15:437-451. 10.1016/j.molcel.2004.06.040, 15304223.
17. Bannwarth S, Figueroa A, Fragaki K, Destroismaisons L, Lacas-Gervais S, Lespinasse F, Vandenbos F, Pradelli LA, Ricci JE, Rotig A, et al. The human MSH5 (MutSHomolog 5) protein localizes to mitochondria and protects the mitochondrial genome from oxidative damage. Mitochondrion 2012, 12:654-665. 10.1016/j.mito.2012.07.111, 22917773.
18. Bocker T, Barusevicius A, Snowden T, Rasio D, Guerrette S, Robbins D, Schmidt C, Burczak J, Croce CM, Copeland T, et al. hMSH5: a human MutS homologue that forms a novel heterodimer with hMSH4 and is expressed during spermatogenesis. Cancer Res 1999, 59:816-822.
19. Her C, Wu X, Bailey SM, Doggett NA. Mouse MutS homolog 4 is predominantly expressed in testis and interacts with MutS homolog 5. Mamm Genome 2001, 12:73-76. 10.1007/s003350010231, 11178747.
20. Her C, Wu X, Griswold MD, Zhou F. Human MutS homologue MSH4 physically interacts with von Hippel-Lindau tumor suppressor-binding protein 1. Cancer Res 2003, 63:865-872.
21. Her C, Wu X, Wan W, Doggett NA. Identification and characterization of the mouse MutS homolog 5: Msh5. Mamm Genome 1999, 10:1054-1061. 10.1007/s003359901161, 10556423.
22. Lee TH, Yi W, Griswold MD, Zhu F, Her C. Formation of hMSH4-hMSH5 heterocomplex is a prerequisite for subsequent GPS2 recruitment. DNA Repair (Amst) 2006, 5:32-42.
23. Santucci-Darmanin S, Neyton S, Lespinasse F, Saunieres A, Gaudray P, Paquis-Flucklinger V. The DNA mismatch-repair MLH3 protein interacts with MSH4 in meiotic cells, supporting a role for this MutL homolog in mammalian meiotic recombination. Hum Mol Genet 2002, 11:1697-1706. 10.1093/hmg/11.15.1697, 12095912.
24. Paquis-Flucklinger V, Santucci-Darmanin S, Paul R, Saunieres A, Turc-Carel C, Desnuelle C. Cloning and expression analysis of a meiosis-specific MutS homolog: the human MSH4 gene. Genomics 1997, 44:188-194. 10.1006/geno.1997.4857, 9299235.
25. Neyton S, Lespinasse F, Lahaye F, Staccini P, Paquis-Flucklinger V, Santucci-Darmanin S. CRM1-dependent nuclear export and dimerization with hMSH5 contribute to the regulation of hMSH4 subcellular localization. Exp Cell Res 2007, 313:3680-3693. 10.1016/j.yexcr.2007.08.010, 17869244.
26. Doldan A, Chandramouli A, Shanas R, Bhattacharyya A, Cunningham JT, Nelson MA, Shi J. Loss of the eukaryotic initiation factor 3f in pancreatic cancer. Mol Carcinog 2008, 47:235-244. 10.1002/mc.20379, 2568992, 17918192.
27. Doldan A, Chandramouli A, Shanas R, Bhattacharyya A, Leong SP, Nelson MA, Shi J. Loss of the eukaryotic initiation factor 3f in melanoma. Mol Carcinog 2008, 47:806-813. 10.1002/mc.20436, 2635928, 18381585.
28. Shi J, Hershey JW, Nelson MA. Phosphorylation of the eukaryotic initiation factor 3f by cyclin-dependent kinase 11 during apoptosis. FEBS Lett 2009, 583:971-977. 10.1016/j.febslet.2009.02.028, 2666973, 19245811.
29. Shi J, Kahle A, Hershey JW, Honchak BM, Warneke JA, Leong SP, Nelson MA. Decreased expression of eukaryotic initiation factor 3f deregulates translation and apoptosis in tumor cells. Oncogene 2006, 25:4923-4936. 10.1038/sj.onc.1209495, 16532022.
30. Moretti J, Chastagner P, Gastaldello S, Heuss SF, Dirac AM, Bernards R, Masucci MG, Israel A, Brou C. The translation initiation factor 3f (eIF3f) exhibits a deubiquitinase activity regulating Notch activation. PLoS Biol 2010, 8:e1000545. 10.1371/journal.pbio.1000545, 2990700, 21124883.
31. Zhang L, Pan X, Hershey JW. Individual overexpression of five subunits of human translation initiation factor eIF3 promotes malignant transformation of immortal fibroblast cells. J Biol Chem 2007, 282:5790-5800.
32. Wen F, Zhou R, Shen A, Choi A, Uribe D, Shi J. The tumor suppressive role of eIF3f and its function in translation inhibition and rRNA degradation. PLoS One 2012, 7:e34194. 10.1371/journal.pone.0034194, 3311619, 22457825.
33. Hinnebusch AG. eIF3: a versatile scaffold for translation initiation complexes. Trends Biochem Sci 2006, 31:553-562. 10.1016/j.tibs.2006.08.005, 16920360.
34. Asano K, Vornlocher HP, Richter-Cook NJ, Merrick WC, Hinnebusch AG, Hershey JW. Structure of cDNAs encoding human eukaryotic initiation factor 3 subunits. Possible roles in RNA binding and macromolecular assembly. J Biol Chem 1997, 272:27042-27052. 10.1074/jbc.272.43.27042, 9341143.
35. Yi W, Wu X, Lee TH, Doggett NA, Her C. Two variants of MutS homolog hMSH5: prevalence in humans and effects on protein interaction. Biochem Biophys Res Commun 2005, 332:524-532. 10.1016/j.bbrc.2005.04.154, 15907804.
36. Bonner WM, Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, Pommier Y. GammaH2AX and cancer. Nat Rev Cancer 2008, 8:957-967. 10.1038/nrc2523, 3094856, 19005492.
37. Dai Y, Grant S. New insights into checkpoint kinase 1 in the DNA damage response signaling network. Clin Cancer Res 2010, 16:376-383. 10.1158/1078-0432.CCR-09-1029, 2939735, 20068082.
38. Xu N, Hegarat N, Black EJ, Scott MT, Hochegger H, Gillespie DA. Akt/PKB suppresses DNA damage processing and checkpoint activation in late G2. J Cell Biol 2010, 190:297-305. 10.1083/jcb.201003004, 2922641, 20679434.
39. Boehme KA, Kulikov R, Blattner C. p53 stabilization in response to DNA damage requires Akt/PKB and DNA-PK. Proc Natl Acad Sci USA 2008, 105:7785-7790. 10.1073/pnas.0703423105, 2409394, 18505846.
40. Fraser M, Harding SM, Zhao H, Coackley C, Durocher D, Bristow RG. MRE11 promotes AKT phosphorylation in direct response to DNA double-strand breaks. Cell Cycle 2011, 10:2218-2232. 10.4161/cc.10.13.16305, 21623170.
41. Deng R, Tang J, Ma JG, Chen SP, Xia LP, Zhou WJ, Li DD, Feng GK, Zeng YX, Zhu XF. PKB/Akt promotes DSB repair in cancer cells through upregulating Mre11 expression following ionizing radiation. Oncogene 2011, 30:944-955. 10.1038/onc.2010.467, 20956948.
42. Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, Pleasance ED, Lau KW, Beare D, Stebbings LA, et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011, 144:27-40. 10.1016/j.cell.2010.11.055, 3065307, 21215367.
43. Shao C, Deng L, Chen Y, Kucherlapati R, Stambrook PJ, Tischfield JA. Mlh1 mediates tissue-specific regulation of mitotic recombination. Oncogene 2004, 23:9017-9024. 10.1038/sj.onc.1208148, 15480418.
44. Lagirand-Cantaloube J, Offner N, Csibi A, Leibovitch MP, Batonnet-Pichon S, Tintignac LA, Segura CT, Leibovitch SA. The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy. EMBO J 2008, 27:1266-1276. 10.1038/emboj.2008.52, 2367397, 18354498.
45. Lee JP, Brauweiler A, Rudolph M, Hooper JE, Drabkin HA, Gemmill RM. The TRC8 ubiquitin ligase is sterol regulated and interacts with lipid and protein biosynthetic pathways. Mol Cancer Res 2010, 8:93-106. 10.1158/1541-7786.MCR-08-0491, 3086825, 20068067.
46. Bolger TA, Folkmann AW, Tran EJ, Wente SR. The mRNA export factor Gle1 and inositol hexakisphosphate regulate distinct stages of translation. Cell 2008, 134:624-633. 10.1016/j.cell.2008.06.027, 2601711, 18724935.
47. Harris TE, Chi A, Shabanowitz J, Hunt DF, Rhoads RE, Lawrence JC. mTOR-dependent stimulation of the association of eIF4G and eIF3 by insulin. EMBO J 2006, 25:1659-1668. 10.1038/sj.emboj.7601047, 1440840, 16541103.
48. Csibi A, Cornille K, Leibovitch MP, Poupon A, Tintignac LA, Sanchez AM, Leibovitch SA. The translation regulatory subunit eIF3f controls the kinase-dependent mTOR signaling required for muscle differentiation and hypertrophy in mouse. PLoS One 2010, 5:e8994. 10.1371/journal.pone.0008994, 2813880, 20126553.
49. Xie A, Kwok A, Scully R. Role of mammalian Mre11 in classical and alternative nonhomologous end joining. Nat Struct Mol Biol 2009, 16:814-818. 10.1038/nsmb.1640, 2730592, 19633669.
50. Rass E, Grabarz A, Plo I, Gautier J, Bertrand P, Lopez BS. Role of Mre11 in chromosomal nonhomologous end joining in mammalian cells. Nat Struct Mol Biol 2009, 16:819-824. 10.1038/nsmb.1641, 19633668.
51. Zhuang J, Jiang G, Willers H, Xia F. Exonuclease function of human Mre11 promotes deletional nonhomologous end joining. J Biol Chem 2009, 284:30565-30573. 10.1074/jbc.M109.059444, 2781611, 19744924.
52. Toulany M, Dittmann K, Fehrenbacher B, Schaller M, Baumann M, Rodemann HP. PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro. DNA Repair (Amst) 2008, 7:1746-1756.
53. Kneitz B, Cohen PE, Avdievich E, Zhu L, Kane MF, Hou H, Kolodner RD, Kucherlapati R, Pollard JW, Edelmann W. MutS homolog 4 localization to meiotic chromosomes is required for chromosome pairing during meiosis in male and female mice. Genes Dev 2000, 14:1085-1097. 316572, 10809667.
54. Her C, Vo AT, Wu X. Evidence for a direct association of hMRE11 with the human mismatch repair protein hMLH1. DNA Repair (Amst) 2002, 1:719-729.
55. Tompkins JD, Wu X, Her C. MutS homologue hMSH5: role in cisplatin-induced DNA damage response. Mol Cancer 2012, 11:10. 10.1186/1476-4598-11-10, 3325843, 22401567.
56. Perrault R, Wang H, Wang M, Rosidi B, Iliakis G. Backup pathways of NHEJ are suppressed by DNA-PK. J Cell Biochem 2004, 92:781-794. 10.1002/jcb.20104, 15211575.